Activated PI3K delta syndrome (APDS) is a rare disorder that affects how the immune system works, leaving individuals vulnerable to repeated infections and other serious health complications that can impact many parts of the body.
Understanding Activated PI3K Delta Syndrome
Activated PI3K delta syndrome, commonly known as APDS, is a rare condition affecting the body’s defense system. This disorder was first identified by researchers in 2013, making it a relatively recent discovery in the field of immune system diseases[1][2]. The syndrome occurs when certain genes that control how immune cells develop and function don’t work properly, leaving people unable to fight off infections the way healthy immune systems do.
People with APDS often have low numbers of white blood cells, which are the body’s main defenders against germs and disease. Specifically, they lack enough B cells and T cells, two types of white blood cells that normally recognize and attack bacteria and viruses before they can cause illness[2]. Without these protective cells working correctly, the body becomes vulnerable to infections that might be mild or easily fought off in people with healthy immune systems.
The condition comes in two forms, known as APDS type 1 and APDS type 2, depending on which gene carries the problematic change. Both types lead to similar problems, though some differences exist in how severely they affect different body systems[3]. The severity of APDS varies greatly from person to person. Some individuals experience multiple severe infections and serious complications, while others may have milder symptoms or even remain mostly unaffected for years[2].
Epidemiology
Activated PI3K delta syndrome is considered an extremely rare disorder. The exact number of people affected worldwide remains unknown because the condition is so new to medical science and likely underdiagnosed[2]. In the United Kingdom, approximately 30 to 40 people have been identified with the condition, which gives some sense of how uncommon it is[15]. In other countries like New Zealand, only a handful of cases have been confirmed[14].
Before APDS was discovered as a distinct condition in 2013, many patients were incorrectly diagnosed with other immune deficiencies, particularly a condition called Common Variable Immunodeficiency or CVID[1][15]. This means the actual number of people with APDS is likely higher than current figures suggest, as some individuals may still be living with incorrect diagnoses.
The disorder affects both males and females equally, with no apparent preference for one sex over the other[15]. While symptoms often begin appearing in childhood or even infancy, the condition can sometimes remain undetected until later in life, depending on how severely it affects each individual[10]. The range of ages at which people are diagnosed can span from very young children to adults, with some people experiencing symptoms for many years before receiving an accurate diagnosis[14].
Causes
Activated PI3K delta syndrome is caused by changes, also called variants or mutations, in specific genes that provide instructions for making proteins crucial to immune system function. These genetic changes occur in one of two genes: PIK3CD or PIK3R1[2][3]. When a person has APDS type 1, the problem lies in the PIK3CD gene, while APDS type 2 results from changes in the PIK3R1 gene.
The PIK3CD gene provides instructions for making a protein called p110 delta, while the PIK3R1 gene instructs cells how to make a protein called p85 alpha. These proteins work together as parts of an enzyme called phosphatidylinositol 3-kinase, or PI3K for short[2]. This enzyme acts like a molecular switch inside white blood cells, turning on important signaling pathways that tell these cells when to grow, divide, and mature into their specialized forms.
The genetic changes that cause APDS are particularly unusual because they make the enzyme work too much, rather than too little. Scientists call these “gain-of-function” variants because the PI3K delta enzyme becomes overactive instead of underactive[2]. When this enzyme is constantly switched on, it disrupts the normal development of B cells and T cells, producing immune cells that don’t mature properly, can’t respond effectively to infections, and die earlier than they should.
APDS can be inherited from a parent who carries the genetic variant, or it can occur spontaneously as a new change in a person’s genes. When the condition appears in a family for the first time with no history of similar problems in previous generations, it’s called a “de novo” variant[14]. Because APDS follows an autosomal dominant inheritance pattern, only one altered copy of the gene is needed to cause the disorder. This means that if one parent has APDS, each of their children has a 50 percent chance of inheriting the condition[3][5].
Risk Factors
The primary risk factor for developing activated PI3K delta syndrome is having a family history of the condition. Since APDS is inherited in an autosomal dominant pattern, children of a parent with the syndrome have a significant chance of inheriting the genetic variant that causes it[5]. Family members who share the same genetic variant may experience very different symptoms, ranging from severe illness to very mild or even no noticeable problems at all[6].
Unlike some diseases where environmental factors or lifestyle choices increase risk, APDS is purely genetic. There are no known behaviors, exposures, or environmental conditions that can cause someone to develop this syndrome if they don’t have the underlying genetic change. The condition is present from birth, even if symptoms don’t appear until later in childhood or adulthood.
When a person is diagnosed with APDS, medical professionals typically recommend that family members, including parents, siblings, and children, undergo genetic testing. This testing can identify whether relatives carry the same genetic variant, even if they haven’t shown symptoms[1]. Identifying carriers is important for several reasons: it allows for monitoring and early intervention if symptoms develop, it informs family planning decisions, and it helps establish appropriate medical care before serious complications arise.
Symptoms
The symptoms of activated PI3K delta syndrome can vary widely from person to person, but certain patterns are common. The most frequent and often earliest symptoms involve repeated and severe infections, particularly affecting the ears, sinuses, and respiratory system[1][3]. These infections typically begin in childhood, often before a child reaches their first birthday. Parents may notice their child repeatedly suffering from ear infections, sinus infections, or respiratory problems that require frequent antibiotic treatments.
Over time, ongoing respiratory tract infections can cause lasting damage to the airways. A condition called bronchiectasis may develop, where the passages leading from the windpipe to the lungs become permanently damaged and widened, making breathing difficult and setting the stage for more infections[2][8]. People with APDS often develop a chronic cough that persists despite treatment.
Beyond bacterial infections, individuals with APDS are vulnerable to persistent viral infections that healthy immune systems would typically control. Common problematic viruses include Epstein-Barr virus, herpes simplex virus, and cytomegalovirus. These viral infections can become chronic, meaning they persist in the body and repeatedly cause symptoms[2][8].
Another characteristic feature of APDS involves abnormal accumulation of white blood cells in various parts of the body. This leads to enlarged lymph nodes, which might appear as swollen lumps under the skin in areas like the neck, armpits, or groin. The condition called lymphadenopathy describes these swollen lymph nodes[2][3]. Similarly, the spleen, an organ involved in immune function, may become enlarged, a condition known as splenomegaly. White blood cells can also form solid masses called nodular lymphoid hyperplasia, particularly in the airways or intestines[8].
Digestive system problems affect many people with APDS. These can include chronic diarrhea, abdominal pain, and conditions resembling inflammatory bowel disease like Crohn’s disease[3]. Some individuals experience a dangerous condition called intussusception, where part of the intestine slides into an adjacent section, causing a blockage.
The immune system dysfunction in APDS can also cause autoimmunity, a confusing situation where the body mistakenly attacks its own healthy tissues and organs[2][3]. This can result in conditions like autoimmune cytopenias, where the body destroys its own blood cells, leading to low counts of red blood cells, white blood cells, or platelets. Some people develop inflammatory arthritis, kidney problems, or liver complications.
Children with APDS may experience developmental delays, both in physical growth and neurological development. Short stature and growth delays are particularly common in APDS type 2[3]. Some individuals also show delays in reaching developmental milestones or have learning difficulties.
One of the most serious concerns with APDS is an increased risk of developing blood cancers, particularly types of lymphoma including Hodgkin lymphoma and non-Hodgkin lymphoma[2][3][8]. This risk appears to result from the constant abnormal proliferation of white blood cells combined with reduced ability to eliminate damaged cells.
Prevention
Because activated PI3K delta syndrome is a genetic condition present from birth, there is no way to prevent someone from being born with the disorder if they inherit the causative gene variant. However, several strategies can help prevent the serious complications that result from APDS, particularly the repeated infections that cause much of the disease’s impact on health and quality of life.
For individuals diagnosed with APDS, regular immunoglobulin replacement therapy serves as a crucial preventive measure. This treatment involves receiving antibodies, either through intravenous infusion or subcutaneous injection, to supplement the body’s inadequate immune response[3][7]. These antibodies help prevent bacterial infections and reduce the frequency and severity of respiratory infections that might otherwise cause permanent lung damage.
Long-term preventive antibiotic therapy is another approach used to reduce infection frequency. By taking antibiotics regularly, even when not actively sick, individuals with APDS can prevent bacterial infections from taking hold[3][7]. Similarly, people who experience recurrent herpes infections may receive preventive antiviral medications like acyclovir or valganciclovir to keep these viruses under control.
Minimizing exposure to infectious agents represents an important lifestyle consideration for people with APDS. While it’s impossible to avoid all germs, certain practical steps can reduce risk. These include maintaining good hand hygiene, avoiding crowds during peak illness seasons when possible, and ensuring household members receive appropriate vaccinations to create a protective environment[4].
Genetic counseling and testing for family members serves as a form of prevention by enabling early diagnosis. When relatives of someone with APDS undergo genetic testing, those found to carry the variant can begin monitoring and preventive treatments before serious complications develop[1]. This proactive approach may prevent some of the long-term organ damage that can occur when the condition goes unrecognized and untreated for years.
Regular medical monitoring allows doctors to catch developing complications early. This might include periodic lung function tests to detect bronchiectasis before it becomes severe, blood tests to watch for autoimmune problems or signs of lymphoma, and imaging studies to monitor organ enlargement[3]. Early detection of these problems allows for earlier intervention, potentially preventing more serious outcomes.
Pathophysiology
Understanding what goes wrong inside the body in activated PI3K delta syndrome helps explain why the symptoms occur. The fundamental problem lies in the overactivity of an enzyme called PI3K delta, which normally plays an important role in white blood cell development and function[6][8]. This enzyme is part of a signaling pathway that tells cells when to grow, divide, mature, and carry out their specialized functions.
In a healthy immune system, the PI3K delta enzyme turns on and off in a carefully controlled manner. It activates when immune cells need to respond to an infection or other immune challenge, then turns off again when the job is done. In people with APDS, genetic changes cause this enzyme to remain active much more than it should be. Scientists describe this as “hyperactivation” of the PI3K/AKT/mTOR signaling pathway[6].
This constant signaling creates chaos in the immune system. B cells and T cells, which normally go through an orderly process of maturation to become specialized defenders, instead receive mixed signals that disrupt their development. The overactive enzyme interferes with the process called differentiation, where immature immune cells transform into mature cells with specific functions[2][8]. The result is immune cells that are stuck in transitional states, unable to properly recognize and respond to bacteria and viruses.
The disrupted cell development creates several specific problems. Many of the B cells and T cells that form are functionally defective—they look somewhat like normal immune cells but can’t do their jobs effectively. Additionally, these cells often die prematurely through a process called activation-induced cell death[4]. This premature death, combined with the production of non-functional cells, leaves the body with inadequate numbers of working B cells and T cells, a condition called lymphopenia[2].
The overactive signaling doesn’t just affect cell function—it also causes cells to multiply excessively. This abnormal proliferation of white blood cells explains the lymphoproliferative features of APDS, such as swollen lymph nodes, enlarged spleen, and the formation of nodular lymphoid hyperplasia in various tissues[2][8]. Essentially, the body produces too many immune cells, but most of them don’t work properly.
The combination of excessive cell proliferation and reduced ability to eliminate damaged or abnormal cells creates an environment where cancerous changes can take hold more easily. This helps explain the increased risk of lymphomas in people with APDS[8]. When cells are constantly dividing and the normal quality control mechanisms are impaired, the chances of a cell developing cancer-causing mutations and surviving long enough to form a tumor increase substantially.
The autoimmune manifestations of APDS also stem from the disrupted immune regulation. Normal immune system function requires a delicate balance between attacking foreign invaders and tolerating the body’s own tissues. The signaling disruptions in APDS upset this balance, leading to situations where immune cells mistakenly identify the body’s own tissues as threats and attack them[3].
